Zevra Therapeutics (ZVRA) Change in Cash (2014 - 2026)
Zevra Therapeutics (ZVRA) posted Change in Cash of $33.2 million for Q1 2026, up 316.58% on a QoQ basis from $8.0 million in Q4 2025, and up 833.59% year-over-year from $3.6 million in Q1 2025.
Zevra Therapeutics (ZVRA) Change in Cash (2014 - 2026) Analysis & Trends
Zevra Therapeutics' Change in Cash history runs 13 years deep, the most recent figure standing at $33.2 million for Q1 2026.
- Quarterly Change in Cash rose 833.59% year-over-year to $33.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $58.3 million (up 1157.45% YoY) and the FY2025 annual result came in at $28.6 million, up 408.95% from the prior year.
- Change in Cash was $33.2 million for Q1 2026 at Zevra Therapeutics, up from $8.0 million in the prior quarter.
- Across five years, Change in Cash topped out at $33.2 million in Q1 2026 and bottomed at -$25.3 million in Q1 2023.
- A 5-year average of -$985352.9 and a median of -$220000.0 in 2023 frame the typical range for Change in Cash.
- Annual changes were most pronounced in 2024 — Change in Cash plunged 9106.36% — and 2025, when it surged 1877.5%.
- Zevra Therapeutics' Change in Cash stood at -$4.7 million in 2022, then soared by 95.28% to -$220000.0 in 2023, then plunged by 9106.36% to -$20.3 million in 2024, then jumped by 139.34% to $8.0 million in 2025, then soared by 316.58% to $33.2 million in 2026.
- Business Quant data shows ZVRA's Change in Cash at $33.2 million in Q1 2026, $8.0 million in Q4 2025, and $6.7 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Cash (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -22.03 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 243.78 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.34 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 417.10 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -153.10 Mn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 57.19 Mn |
| 10 | Zevra Therapeutics | 239.71 Mn | 39.10 Mn | 34.32 Mn | 33.19 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 33.19 Mn |
| Dec 31, 2025 | 7.97 Mn |
| Sep 30, 2025 | 6.73 Mn |
| Jun 30, 2025 | 10.37 Mn |
| Mar 31, 2025 | 3.56 Mn |
| Dec 31, 2024 | -20.25 Mn |
| Sep 30, 2024 | 14.78 Mn |
| Jun 30, 2024 | -3.59 Mn |
| Mar 31, 2024 | -200,000.00 |
| Dec 31, 2023 | -220,000.00 |
| Sep 30, 2023 | -22.93 Mn |
| Jun 30, 2023 | 26.02 Mn |
| Mar 31, 2023 | -25.29 Mn |
| Dec 31, 2022 | -4.66 Mn |
| Sep 30, 2022 | -6.65 Mn |
| Jun 30, 2022 | -23.43 Mn |
| Mar 31, 2022 | -12.13 Mn |
| Dec 31, 2021 | -19.16 Mn |
| Sep 30, 2021 | -792,000.00 |
| Jun 30, 2021 | 56.27 Mn |